Faster AMR Drug Reviews And A New Pathogen List On Health Canada’s Agenda
Health Canada is seeking comments on a proposed list of pathogens that is designed to help the government department understand how it can stimulate the submission of new drugs for beating antimicrobial resistance and facilitate their regulatory approval.
You may also be interested in...
The European Commission has unveiled its second action plan to tackle antimicrobial resistance, this time under the “one health” banner. This new initiative includes a set of guidelines for use by the EU member states when planning their anti-resistance strategies.
The European Medicines Agency has given the Pink Sheet more detail on its recent agreement with its counterparts in the US and Japan to align certain clinical data requirement to stimulate the development of new treatments to fight antimicrobial resistance.
The European Medicines Agency wants AMR drug developers to apply for entry on its priority medicine (PRIME) scheme.